# Cochrane

# Trusted evidence.

# Informed decisions.

# Library

# Better health.

# CTRI/2021/03/032131 (Continued)

# Contact information

Ajit Sood

# Cochrane Database of Systematic Reviews

Department of Gastroenterology, Third Floor Dayanand Medical College and Hospital, Ludhiana, Punjab, India; email: ajitsood10@gmail.com

# Notes

EUCTR 2019-003816-29

# Study name

Fecal microbiota transplantation in Crohn's disease as relay after anti-TNF withdrawal

# Methods

RCT conducted in France

# Participants

# Inclusion criteria

- Age 18 years < 75 years
- CD (according to the Lennard-Jones criteria) for ≥ 6 months
- In steroid-free clinical remission for ≥ 6 months under anti-TNF agent (no clinical evidence of flare or change in CD-specific treatment and CDAI < 150 the week before inclusion [see Addendum 2 in publication]) with willingness to withdraw anti-TNF treatment
- For females of child-bearing age: active birth control during at least the period of treatment (week 52)
- With health insurance (AME except)
- Informed written consent

# Exclusion criteria

- CD complication requiring surgical treatment
- Contraindication to colonoscopy or anesthesia
- Pregnancy or lactation during the study (see Addendum 4 of paper)
- Diagnosis of CD restricted to upper gastrointestinal tract (esophagus, stomach, duodenum, jejunum)
- History of bowel resection
- Current stoma (ileostomy or colostomy) or stoma in last 6 months or any other intra-abdominal surgery within 3 months prior to inclusion
- Participation in any other interventional study
- People under legal protection

# Interventions

# Experimental arm

FMT in rectal solution or capsule

# Control arm

Sham FMT

# Outcomes

# Primary outcome

Clinical remission (defined by CDAI < 150) at week 52 (V8) without any flare between week 0 (colonoscopy [V2]) and week 52 (V8)

# Secondary outcomes

- Relapse-free survival rate from week 0 (V2) to week 52 (V8)
- Proportion of endoscopic remission (SES-CD = 2) at week 52 (V8) and change (in %) in endoscopic score (SES-CD) between week 0 (V2) and 52 (V8)

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.